Physician profile
Paul Stasko
NPI 1770715237
$16,317.04
in general payments reported to CMS, 2019-2025
24 companies · $798 in 2025
The $798 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,308 · 2020: $3,680 · 2021: $3,854 · 2022: $1,433 · 2023: $819 · 2024: $426 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,042.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,225.31 | 2019-2024 | Arthrex |
| Prodigy Surgical Distribution, INC. | $6,654.16 | 2019-2025 | |
| Treace Medical Concepts, INC. | $551.85 | 2023-2025 | |
| Integra Lifesciences Corporation | $262.22 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $248.25 | 2019-2025 | A.L.P.S. |
| Paragon 28, INC. | $189.08 | 2022-2025 | Portfolio |
| Smith+Nephew, INC. | $177.58 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Spatial Frame |
| Organogenesis INC. | $174.15 | 2019-2024 | Puraply, Affinity |
| Innovation Technologies INC | $142.22 | 2023 | Irrisept |
| Bioventus LLC | $126.09 | 2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $121.81 | 2023 | Trinity Elite, Truelok, Truelok System |
| Nevro Corp. | $97.73 | 2023 | Senza |
| Kci USA, INC. | $85.89 | 2022 | |
| Amniox Medical, INC. | $60.32 | 2020 | |
| Advanced Oxygen Therapy INC. | $36.30 | 2024-2025 | Topical Oxygen Chamber For Extremities |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $30.67 | 2021-2023 | Krystexxa |
| Misonix INC | $25.82 | 2020 | |
| Amgen INC. | $17.60 | 2024 | Krystexxa |
| Ethicon US, LLC | $17.28 | 2024 | Vistaseal |
| Baudax Bio INC. | $16.34 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.58 | 2025 | Nuzyra |
| Depuy Synthes Sales INC. | $15.23 | 2023 | Orthovisc, Monovisc |
| Biotissue Holdings INC. | $14.52 | 2021 | |
| Arthrosurface Incorporated | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Stasko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.